ProQR Announces Presentations at the European CF Conference and the JMP Life Science Conference Press release LEIDEN, the Netherlands, June 01, 2016 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. Junho 01, 2016
ProQR Announces the Grant of two Key Patents, protecting QR-010 for Cystic Fibrosis in the US and EU Press release … from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633545. … Abril 03, 2017
ProQR Presents in vivo Proof of Concept Data for the Axiomer® RNA Editing Platform Technology Press release Key updates Setembro 21, 2017
ProQR Announces Clinical Data Presentations and Investor & Analyst Event at NACFC Press release … from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633545. … Setembro 27, 2016
ProQR Receives Fast Track Designation from FDA for QR-010 for Cystic Fibrosis Press release LEIDEN, the Netherlands, July 19, 2016 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. Julho 19, 2016
ProQR Appoints David M. Rodman, MD as Chief Development Strategy Officer Press release … Officer of ProQR. “Between Gerard (Platenburg, Chief Innovation Officer), Dave and Noreen we cover all key … Março 27, 2017
ProQR Announces Management Change and Key Promotions Press release … development. Dr. Friesen has served as Head of Innovation at the Company since June 2016. He obtained a M.S. … Outubro 26, 2017
ProQR Completes Dosing of Cystic Fibrosis Patients in QR-010 Phase 1b Trial Press release Key Updates Agosto 29, 2017
ProQR to present QR-010 data at the European Cystic Fibrosis Society Conference and provides an update on the ongoing Phase 1b trial Press release Key Updates Junho 08, 2017
ProQR to Release Topline Data from Proof of Concept Study of QR-010 in Cystic Fibrosis Patients at NACFC Press release LEIDEN, the Netherlands, June 21, 2016 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. Junho 21, 2016